Literature DB >> 11870953

Drug-eluting stents for the prevention of restenosis: in quest for the Holy Grail.

Bonnie L Hiatt1, Fumaiki Ikeno, Alan C Yeung, Andrew J Carter.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11870953     DOI： 10.1002/ccd.10161

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN： 1522-1946            Impact factor:   2.692


× No keyword cloud information.
  4 in total

Review 1.  Delivery of large biopharmaceuticals from cardiovascular stents: a review.

Authors:  Hironobu Takahashi; Didier Letourneur; David W Grainger
Journal:  Biomacromolecules       Date:  2007-10-12       Impact factor: 6.988

2.  New stent design for use in small coronary arteries during percutaneous coronary intervention.

Authors:  Juan F Granada; Barbara A Huibregtse; Keith D Dawkins
Journal:  Med Devices (Auckl)       Date:  2010-10-19

Review 3.  Biomaterials in urology.

Authors:  Darren T Beiko; Bodo E Knudsen; James D Watterson; John D Denstedt
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

Review 4.  Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).

Authors:  Imad Sheiban; Gianluca Villata; Mario Bollati; Dario Sillano; Marzia Lotrionte; Giuseppe Biondi-Zoccai
Journal:  Vasc Health Risk Manag       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.